Biochemistry
-
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
This article has 7 authors:Reviewed by ScreenIT
-
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
This article has 7 authors:Reviewed by ScreenIT
-
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
This article has 4 authors:Reviewed by ScreenIT
-
Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3
This article has 5 authors:Reviewed by ScreenIT
-
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
This article has 12 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution
This article has 12 authors:Reviewed by ScreenIT
-
Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease
This article has 27 authors:Reviewed by ScreenIT
-
Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target
This article has 28 authors:Reviewed by ScreenIT
-
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
This article has 8 authors:Reviewed by ScreenIT
-
Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights and Implications for the Design of Diagnostics and Therapeutics
This article has 3 authors:Reviewed by ScreenIT